Race against time: smart trial aims to slash pneumonia deaths
NCT ID NCT07152587
Summary
This study is testing different doses of steroid medication (corticosteroids) for adults in the ICU with severe pneumonia caught outside the hospital. It will enroll 1,500 patients to see which steroid dose is most effective at reducing deaths within 28 days. The trial uses a smart, adaptive design that adjusts as it goes, aiming to give more patients the better-performing treatment sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.